Global Mesalazine Competitive Landscape Professional Research Report 2024

Research Summary

Mesalazine, also known as mesalamine, is a medication used for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn's disease. It belongs to a class of drugs called aminosalicylates and works locally in the gastrointestinal tract to reduce inflammation. Mesalazine is available in various forms, including oral tablets, capsules, extended-release tablets, suppositories, and enemas. It is believed to exert its therapeutic effects by inhibiting the production of inflammatory mediators and promoting the healing of the intestinal lining. Mesalazine has been shown to alleviate symptoms of IBD, such as abdominal pain, diarrhea, and rectal bleeding, and to maintain remission in patients with these conditions. As with any medication, mesalazine may have potential side effects, and its use should be closely monitored and guided by a healthcare professional.

According to DIResearch's in-depth investigation and research, the global Mesalazine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Mesalazine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Mesalazine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Mesalazine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Mesalazine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Mesalazine Include:

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalazine Product Segment Include:

Above 97 %

Above 98 %

Above 99 %

Mesalazine Product Application Include:

Tablets

Capsules

Pellet and Granule

Suppository

Enema

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Mesalazine Industry PESTEL Analysis

Chapter 3: Global Mesalazine Industry Porter's Five Forces Analysis

Chapter 4: Global Mesalazine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Mesalazine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Mesalazine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Mesalazine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Mesalazine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Mesalazine Product by Type

1.2.1 Global Mesalazine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Above 97 %

1.2.3 Above 98 %

1.2.4 Above 99 %

1.3 Mesalazine Product by Application

1.3.1 Global Mesalazine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Pellet and Granule

1.3.5 Suppository

1.3.6 Enema

1.3.7 Others

1.4 Global Mesalazine Market Revenue and Sales Analysis

1.4.1 Global Mesalazine Market Size Analysis (2019-2030)

1.4.2 Global Mesalazine Market Sales Analysis (2019-2030)

1.4.3 Global Mesalazine Market Sales Price Trend Analysis (2019-2030)

1.5 Mesalazine Market Development Status and Trends

1.5.1 Mesalazine Industry Development Status Analysis

1.5.2 Mesalazine Industry Development Trends Analysis

2 Mesalazine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Mesalazine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Mesalazine Market Analysis by Regions

4.1 Mesalazine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Mesalazine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Mesalazine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Mesalazine Revenue Forecast by Region (2025-2030)

4.3 Global Mesalazine Sales and Forecast Analysis (2019-2030)

4.3.1 Global Mesalazine Sales and Market Share by Region (2019-2024)

4.3.2 Global Mesalazine Sales Forecast by Region (2025-2030)

4.4 Global Mesalazine Sales Price Trend Analysis (2019-2030)

5 Global Mesalazine Market Size by Type and Application

5.1 Global Mesalazine Market Size by Type

5.1.1 Global Mesalazine Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Mesalazine Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Mesalazine Market Size by Application

5.2.1 Global Mesalazine Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Mesalazine Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Mesalazine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Mesalazine Market Size by Type

6.3.1 North America Mesalazine Sales by Type (2019-2030)

6.3.2 North America Mesalazine Revenue by Type (2019-2030)

6.4 North America Mesalazine Market Size by Application

6.4.1 North America Mesalazine Sales by Application (2019-2030)

6.4.2 North America Mesalazine Revenue by Application (2019-2030)

6.5 North America Mesalazine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Mesalazine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Mesalazine Market Size by Type

7.3.1 Europe Mesalazine Sales by Type (2019-2030)

7.3.2 Europe Mesalazine Revenue by Type (2019-2030)

7.4 Europe Mesalazine Market Size by Application

7.4.1 Europe Mesalazine Sales by Application (2019-2030)

7.4.2 ? Europe Mesalazine Revenue by Application (2019-2030)

7.5 Europe Mesalazine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Mesalazine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Mesalazine Market Size by Type

8.3.1 China Mesalazine Sales by Type (2019-2030)

8.3.2 China Mesalazine Revenue by Type (2019-2030)

8.4 China Mesalazine Market Size by Application

8.4.1 China Mesalazine Sales by Application (2019-2030)

8.4.2 China Mesalazine Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Mesalazine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Mesalazine Market Size by Type

9.3.1 APAC (excl. China) Mesalazine Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Mesalazine Revenue by Type (2019-2030)

9.4 APAC (excl. China) Mesalazine Market Size by Application

9.4.1 APAC (excl. China) Mesalazine Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Mesalazine Revenue by Application (2019-2030)

9.5 APAC (excl. China) Mesalazine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Mesalazine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Mesalazine Market Size by Type

10.3.1 Latin America Mesalazine Sales by Type (2019-2030)

10.3.2 Latin America Mesalazine Revenue by Type (2019-2030)

10.4 Latin America Mesalazine Market Size by Application

10.4.1 Latin America Mesalazine Sales by Application (2019-2030)

10.4.2 Latin America Mesalazine Revenue by Application (2019-2030)

10.5 Latin America Mesalazine Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Mesalazine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Mesalazine Market Size by Type

11.3.1 Middle East & Africa Mesalazine Sales by Type (2019-2030)

11.3.2 Middle East & Africa Mesalazine Revenue by Type (2019-2030)

11.4 Middle East & Africa Mesalazine Market Size by Application

11.4.1 Middle East & Africa Mesalazine Sales by Application (2019-2030)

11.4.2 Middle East & Africa Mesalazine Revenue by Application (2019-2030)

11.5 Middle East & Africa Mesalazine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Mesalazine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Mesalazine Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Mesalazine Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Mesalazine Average Sales Price by Manufacturers (2020-2024)

12.2 Mesalazine Competitive Landscape Analysis and Market Dynamic

12.2.1 Mesalazine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 PharmaZell

13.1.1 PharmaZell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 PharmaZell Mesalazine Product Portfolio

13.1.3 PharmaZell Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Syntese A/S

13.2.1 Syntese A/S Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Syntese A/S Mesalazine Product Portfolio

13.2.3 Syntese A/S Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Cambrex Corporation

13.3.1 Cambrex Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Cambrex Corporation Mesalazine Product Portfolio

13.3.3 Cambrex Corporation Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Divis Laboratories

13.4.1 Divis Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Divis Laboratories Mesalazine Product Portfolio

13.4.3 Divis Laboratories Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Chemi SpA

13.5.1 Chemi SpA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Chemi SpA Mesalazine Product Portfolio

13.5.3 Chemi SpA Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Ipca Laboratories

13.6.1 Ipca Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Ipca Laboratories Mesalazine Product Portfolio

13.6.3 Ipca Laboratories Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Hangzhou Brother

13.7.1 Hangzhou Brother Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Hangzhou Brother Mesalazine Product Portfolio

13.7.3 Hangzhou Brother Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Lianyungang Fengheng Biopharm

13.8.1 Lianyungang Fengheng Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio

13.8.3 Lianyungang Fengheng Biopharm Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Lasa Loboratory

13.9.1 Lasa Loboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Lasa Loboratory Mesalazine Product Portfolio

13.9.3 Lasa Loboratory Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Corden Pharma Bergamo

13.10.1 Corden Pharma Bergamo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Corden Pharma Bergamo Mesalazine Product Portfolio

13.10.3 Corden Pharma Bergamo Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 Erregierre SpA

13.11.1 Erregierre SpA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Erregierre SpA Mesalazine Product Portfolio

13.11.3 Erregierre SpA Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 CTX Lifescience

13.12.1 CTX Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 CTX Lifescience Mesalazine Product Portfolio

13.12.3 CTX Lifescience Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 Ishita Active Pharma Ingredients

13.13.1 Ishita Active Pharma Ingredients Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Ishita Active Pharma Ingredients Mesalazine Product Portfolio

13.13.3 Ishita Active Pharma Ingredients Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.14 YC Biotech (Jiangsu)

13.14.1 YC Biotech (Jiangsu) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 YC Biotech (Jiangsu) Mesalazine Product Portfolio

13.14.3 YC Biotech (Jiangsu) Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.15 Xinxiang Tianfeng Fine Chemical

13.15.1 Xinxiang Tianfeng Fine Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio

13.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Mesalazine Industry Chain Analysis

14.2 Mesalazine Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Mesalazine Typical Downstream Customers

14.4 Mesalazine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support